Director/PDMR Shareholding

RNS Number : 4622P

GlaxoSmithKline PLC

01 October 2013

 



 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the Directors' interests in the Ordinary Shares and American Depositary Shares (ADSs) of GlaxoSmithKline plc.

On 30 September 2013, the Company's Non-Executive Directors were allocated notional Ordinary Shares at a price of £15.74 per Ordinary Share, and notional ADSs at a price of $50.53 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 July 2013 to 30 September 2013:

Non Executive Director	Ordinary Shares	American Depositary Shares (ADSs)
Sir Christopher Gent	2,700.127
Professor Sir Roy Anderson	456.639
Dr Stephanie Burns		456.882
Stacey Cartwright	337.516
Lynn  Elsenhans		822.388
Judy Lewent		387.357
Sir Deryck Maughan		1,152.137
Dr Daniel Podolsky		863.509
Tom de Swaan	416.931
Jing Ulrich		228.441
Hans Wijers	337.516
Sir Robert Wilson	337.516

The Company and the Non-Executive Directors were informed of these allocations on 1 October 2013.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

1 October 2013

 

END

 

 

RDSEFLFBXBFFFBQ